Definitive Contract 75N93022C00044
Award Date
9/30/22
Potential Completion Date
12/15/24
Potential Value
$597K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Ampersand Biosciences LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
UPPER ST REG, NY 12945, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to Ampersand Biosciences LLC, a woman-owned small business. The $599,987 contract is for the development of monoclonal antibodies to chemokines in the ferret model of respiratory disease. The contract is not set aside. Ampersand Biosciences is a biotechnology research company that has received multiple prior NIAID...
Ampersand Biosciences LLC has been awarded a $572,817 firm fixed price contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop ferret reagents for use in characterizing immune responses to respiratory infections in the ferret disease model. The contract is associated with the Small Business Innovation Research Program Phase I solicitation and will support the prime contractor's work through August 2022. The total award has been set aside...
This is a $1,084,824.00 firm-fixed-price definitive contract awarded to Ampersand Biosciences LLC, a woman-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 30, 2024. The contract is for the further characterization and validation of monoclonal antibodies to study respiratory diseases. The work will be performed in Upper St Reg, NY 12945, USA and has an ultimate completion date of September 29, 2026. This contract does not have a set-aside...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization, for preclinical evaluation of influenza vaccines and vaccine strategies using ferret models. The contract has a ceiling value of $3,291,183.38 and is funded as a cost-plus-fixed-fee arrangement. It was issued under NIAID's Preclinical Models of Infectious Diseases...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price definitive contract valued at $585,999.00 to Protein Innovation Labs, Inc., a small business concern, for the provision of reagents to support immunologic analysis of non-mammalian models. This contract was awarded under the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) Small Business Innovation...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Southern Research Institute, a non-profit research organization, for $54,095.00. The contract is for ferret studies and analysis, which are likely related to NIAID's research on emerging infectious diseases. Southern Research Institute has a history of providing drug discovery, preclinical services, and other research and development support to various government...
This is a cost-no-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to the American Foundation For Biological Research (doing business as Biomedical Research Institute), a non-profit organization. The $523,459 contract is for the maintenance, development, and production of schistosomiasis parasites, reagents, and assays, which supports the NIAID's research on...
This is a $18,576,013.05 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to the nonprofit research institute Access To Advanced Health Institute (AAHI), also known as Aahi, Idri, and Infectious Disease Research Institute. The contract is for the development of vaccine candidates for biodefense, antimicrobial resistant (AMR) infections, and emerging infectious...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract, worth a guaranteed minimum of $50,000.00, was awarded to the University of Massachusetts Medical School (UMass Medical) to provide animal models of infectious diseases research under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery vehicle (IDV). The contract is a firm...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,971.50 firm fixed price purchase order to Cyagen Biomodels LLC for conditional knockout mouse model services (Ambis #2185806). As the prime contractor, Cyagen Biomodels LLC will deliver the requested mouse models from its facility in Santa Clara, California under the terms of this contract over a six-month period concluding in March 2024. The award...